ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating... [read full story]
|
RELATED
|
|
Palifosfamide prolongs progression-free survival by at least 50% -- NEW YORK--(BUSINESS WIRE)--Nov 6, 2009 - ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS)...
Ziopharm Oncology, Inc. achieved positive data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) in patients with unresectable or metastatic soft tissue sarcoma. Having achieved the study’s...
NEW YORK----ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide treating patients with...
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM,...
ZIOPHARM Oncology, Inc (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM,...
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM,...
Palifosfamide prolongs progression-free survival by at least 50% -- Palifosfamide is easily administered as an out-patient treatment, and generally well-tolerated. ”These interim results are very promising, indicating a...
NEW YORK - ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide...
Obesity, Metabolic Problems, Medicines & Remedies, Female Health, Scientific Discoveries, Eating Disorders, Health Care, Entertainment and lifestyle, Human Reproduction, Lifestyle, Food, Beverage & Tobacco, Mental Health & Behavior, Construction, Pharmaceuticals, Ambulatory Health Care, Cancer by Body Location, Construction & Real Estate, Cancer Treatments, Male Health, Testicular Cancer, Patients, Breast Diseases, Breast Cancer, Lifestyle - Weight Loss, Oncology, Building Construction, Infertility, Medical Research, Cancers, Morbid Obesity, Cancer Therapy, Coeliac disease, Food Safety, Schering, Aethlon Medical, Genentech, Biogen, Ziopharm Oncology
